Summary
4.35 -0.01(-0.11%)10/04/2024
Definitive Healthcare Corp (DH)
![]()
Definitive Healthcare Corp (DH)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 0.00 | -1.36 | -3.44 | -18.79 | -45.69 | -42.45 | 0.00 | -57.07 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 4.35 | |
| Open | 4.47 | |
| High | 4.50 | |
| Low | 4.32 | |
| Volume | 223,368 | |
| Change | 0.00 | |
| Change % | 0.00 | |
| Avg Volume (20 Days) | 344,491 | |
| Volume/Avg Volume (20 Days) Ratio | 0.65 | |
| 52 Week Range | 3.19 - 10.61 | |
| Price vs 52 Week High | -59.05% | |
| Price vs 52 Week Low | 36.21% | |
| Range | -2.80 | |
| Gap Up/Down | 0.09 | |
Fundamentals | ||
| Market Capitalization (Mln) | 509 | |
| EBIDTA | 46,577,000 | |
| PE Ratio | 0.0000 | |
| PEG Ratio | 0.0000 | |
| WallStreet Target Price | 44.78 | |
| Book Value | 7.8500 | |
| Earnings Per Share | -0.6700 | |
| EPS Estimate Current Quarter | 0.0200 | |
| EPS Estimate Next Quarter | 0.0400 | |
| EPS Estimate Current Year | 0.1200 | |
| EPS Estimate Next Year | 0.2700 | |
| Diluted EPS (TTM) | -0.6700 | |
| Revenues | ||
| Profit Marging | -0.3725 | |
| Operating Marging (TTM) | -0.0873 | |
| Return on asset (TTM) | 0.0000 | |
| Return on equity (TTM) | 0.0000 | |
| Revenue TTM | 153,499,008 | |
| Revenue per share TTM | 1.7390 | |
| Quarterly Revenue Growth (YOY) | 0.4330 | |
| Quarterly Earnings Growth (YOY) | 0.0000 | |
| Gross Profit (TTM) | 107,232,000 | |
| Dividends | ||
| Dividend Share | 0.0000 | |
| Dividend Yield | ||
| Valuations | ||
| Trailing PE | 0.0000 | |
| Forward PE | 105.2632 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 4.3106 | |
| Revenue Enterprise Value | 19.9959 | |
| EBITDA Enterprise Value | 101.4157 | |
| Shares | ||
| Shares Outstanding | 99,263,296 | |
| Shares Float | 30,619,433 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 3.96 | |
| Institutions (%) | 84.39 | |
10/04 00:03 EST - gurufocus.com
Irenic Capital Management LP's Strategic Acquisition in Definitive Healthcare Corp
On September 30, 2024, Irenic Capital Management LP (Trades, Portfolio) made a significant addition to its investment portfolio by acquiring 6,413,185 shares of Definitive Healthcare Corp (DH, Financial). This transaction, executed at a price of $4.47 per share, marks a substantial increase in the firm's holdings in the healthcare sector, reflecting a strategic move to bolster its position in this industry.
Irenic Capital Management LP's Strategic Acquisition in Definitive Healthcare Corp
On September 30, 2024, Irenic Capital Management LP (Trades, Portfolio) made a significant addition to its investment portfolio by acquiring 6,413,185 shares of Definitive Healthcare Corp (DH, Financial). This transaction, executed at a price of $4.47 per share, marks a substantial increase in the firm's holdings in the healthcare sector, reflecting a strategic move to bolster its position in this industry.
09/03 17:55 EST - businesswire.com
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Definitive Healthcare Corp. (DH) on Behalf of Investors
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (NASDAQ: DH) investors concerning the Company's possible violations of federal securities laws. On July 30, 2024, Definitive Healthcare disclosed that it took a $363.6 million goodwill impairment, and that as a result the Company was reducing its 2024 fiscal year guidance. On this news, Definitive Healthcare's stock price f.
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Definitive Healthcare Corp. (DH) on Behalf of Investors
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (NASDAQ: DH) investors concerning the Company's possible violations of federal securities laws. On July 30, 2024, Definitive Healthcare disclosed that it took a $363.6 million goodwill impairment, and that as a result the Company was reducing its 2024 fiscal year guidance. On this news, Definitive Healthcare's stock price f.
08/29 16:05 EST - globenewswire.com
Definitive Healthcare to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
FRAMINGHAM, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Financial Officer, Rick Booth, will present at the Morgan Stanley 22nd Annual Global Healthcare Conference.
Definitive Healthcare to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
FRAMINGHAM, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Financial Officer, Rick Booth, will present at the Morgan Stanley 22nd Annual Global Healthcare Conference.
08/27 09:15 EST - globenewswire.com
Definitive Healthcare launches powerful consumer analytics and activation solution to more industries with Population Intelligence expansion
Population Intelligence empowers businesses to improve marketing campaigns and digital advertising performance with combined clinical and consumer insights Population Intelligence empowers businesses to improve marketing campaigns and digital advertising performance with combined clinical and consumer insights
Definitive Healthcare launches powerful consumer analytics and activation solution to more industries with Population Intelligence expansion
Population Intelligence empowers businesses to improve marketing campaigns and digital advertising performance with combined clinical and consumer insights Population Intelligence empowers businesses to improve marketing campaigns and digital advertising performance with combined clinical and consumer insights
08/19 12:12 EST - seekingalpha.com
Definitive Healthcare: Poor Near-Term Outlook, But New CEO May Change Things
DH remains a hold rating due to its poor near-term outlook and recent results. 2Q24 results show decelerating growth, client count decline, and an elongated sales cycle. New CEO Kevin Coop could be a game changer, but there is no reason to invest in DH at this point.
Definitive Healthcare: Poor Near-Term Outlook, But New CEO May Change Things
DH remains a hold rating due to its poor near-term outlook and recent results. 2Q24 results show decelerating growth, client count decline, and an elongated sales cycle. New CEO Kevin Coop could be a game changer, but there is no reason to invest in DH at this point.
08/05 22:50 EST - seekingalpha.com
Definitive Healthcare Corp. (DH) Q2 2024 Earnings Call Transcript
Definitive Healthcare Corp. (NASDAQ:DH ) Q2 2024 Earnings Conference Call August 5, 2024 5:00 PM ET Company Participants Matt Ruderman - Investor Relations Kevin Coop - Chief Executive Officer Rick Booth - Chief Financial Officer Conference Call Participants Saket Kalia - Barclays Craig Hettenbach - Morgan Stanley Joe Vruwink - Baird David Grossman - Stifel Matt Shea - Needham & Company Hanna Lee - Bank of America John McCary - Raymond James Jared Haase - William Blair Operator Welcome to Definitive Healthcare's Q2 2024 Earnings Call. At this time, all participants are in a listen-only mode.
Definitive Healthcare Corp. (DH) Q2 2024 Earnings Call Transcript
Definitive Healthcare Corp. (NASDAQ:DH ) Q2 2024 Earnings Conference Call August 5, 2024 5:00 PM ET Company Participants Matt Ruderman - Investor Relations Kevin Coop - Chief Executive Officer Rick Booth - Chief Financial Officer Conference Call Participants Saket Kalia - Barclays Craig Hettenbach - Morgan Stanley Joe Vruwink - Baird David Grossman - Stifel Matt Shea - Needham & Company Hanna Lee - Bank of America John McCary - Raymond James Jared Haase - William Blair Operator Welcome to Definitive Healthcare's Q2 2024 Earnings Call. At this time, all participants are in a listen-only mode.
08/05 18:55 EST - zacks.com
Definitive Healthcare Corp. (DH) Meets Q2 Earnings Estimates
Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.09 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.08 per share a year ago.
Definitive Healthcare Corp. (DH) Meets Q2 Earnings Estimates
Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.09 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.08 per share a year ago.
08/05 16:05 EST - globenewswire.com
Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2024
FRAMINGHAM, Mass., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended June 30, 2024.
Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2024
FRAMINGHAM, Mass., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended June 30, 2024.
07/22 16:05 EST - globenewswire.com
Definitive Healthcare Announces Timing of Its Second Quarter 2024 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its second quarter ended June 30, 2024, on Monday, August 5, 2024 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results.
Definitive Healthcare Announces Timing of Its Second Quarter 2024 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its second quarter ended June 30, 2024, on Monday, August 5, 2024 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results.
07/09 09:47 EST - globenewswire.com
Definitive Healthcare launches redesigned mobile app to enhance access to healthcare commercial intelligence
DH View Suite gives sales and marketing teams instant access to critical intelligence right from their mobile devices DH View Suite gives sales and marketing teams instant access to critical intelligence right from their mobile devices
Definitive Healthcare launches redesigned mobile app to enhance access to healthcare commercial intelligence
DH View Suite gives sales and marketing teams instant access to critical intelligence right from their mobile devices DH View Suite gives sales and marketing teams instant access to critical intelligence right from their mobile devices
06/25 18:57 EST - globenewswire.com
Definitive Healthcare Corp. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FRAMINGHAM, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that Definitive Healthcare's Board of Directors (the “Board”) granted inducement awards consisting of 1,137,038 performance-based restricted stock units (“PSUs”) and 1,170,047 time-based restricted stock units (“RSUs”) to Kevin Coop, Definitive Healthcare's new Chief Executive Officer and member of the Board, effective June 24, 2024. The awards were granted as an inducement material to Mr. Coop's commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4).
Definitive Healthcare Corp. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FRAMINGHAM, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that Definitive Healthcare's Board of Directors (the “Board”) granted inducement awards consisting of 1,137,038 performance-based restricted stock units (“PSUs”) and 1,170,047 time-based restricted stock units (“RSUs”) to Kevin Coop, Definitive Healthcare's new Chief Executive Officer and member of the Board, effective June 24, 2024. The awards were granted as an inducement material to Mr. Coop's commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4).
06/11 09:15 EST - globenewswire.com
Definitive Healthcare Wins 2024 Databricks Healthcare and Life Sciences Partner of the Year Award
Empowering healthcare and life science organizations with faster insights through seamless data sharing Empowering healthcare and life science organizations with faster insights through seamless data sharing
Definitive Healthcare Wins 2024 Databricks Healthcare and Life Sciences Partner of the Year Award
Empowering healthcare and life science organizations with faster insights through seamless data sharing Empowering healthcare and life science organizations with faster insights through seamless data sharing
06/03 13:08 EST - globenewswire.com
Definitive Healthcare Publishes 2023 Sustainability Report
FRAMINGHAM, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today released its 2023 sustainability report.
Definitive Healthcare Publishes 2023 Sustainability Report
FRAMINGHAM, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today released its 2023 sustainability report.
05/29 16:05 EST - globenewswire.com
Definitive Healthcare to Present at the Stifel 2024 Cross Sector Insight Conference
FRAMINGHAM, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Founder, Interim CEO, and Executive Chairman, Jason Krantz, will present at the Stifel 2024 Cross Sector Insight Conference.
Definitive Healthcare to Present at the Stifel 2024 Cross Sector Insight Conference
FRAMINGHAM, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Founder, Interim CEO, and Executive Chairman, Jason Krantz, will present at the Stifel 2024 Cross Sector Insight Conference.
05/28 08:00 EST - globenewswire.com
Definitive Healthcare Appoints Kevin Coop as CEO for Next Phase of Company's Growth
Mr. Coop brings more than 30 years of Operations, Product and Revenue Expertise Mr. Coop brings more than 30 years of Operations, Product and Revenue Expertise
Definitive Healthcare Appoints Kevin Coop as CEO for Next Phase of Company's Growth
Mr. Coop brings more than 30 years of Operations, Product and Revenue Expertise Mr. Coop brings more than 30 years of Operations, Product and Revenue Expertise
05/20 09:00 EST - https://www.accesswire.com
Definitive Business Solutions Releases AI-Enhanced Version of Definitive Pro for Project Portfolio Management (PPM)
Definitive Pro Elevates Project Portfolio Management (PPM) with Generative AIRESTON, VA / ACCESSWIRE / May 20, 2024 / Definitive Business Solutions, Inc. (Definitive), a leader in innovative project portfolio management solutions, proudly announces the release of the AI-enhanced version of Definitive Pro. This latest iteration of Definitive Pro integrates comprehensive AI features designed to revolutionize how organizations manage their project portfolios, optimizing decision-making and aligning projects seamlessly with strategic objectives.Definitive Logo Definitive Business Solutions, Inc. Logo"In today's dynamic business environment, the ability to make informed, strategic decisions is paramount," said John Sammarco, President of Definitive. "The new AI capabilities in Definitive Pro empower portfolio managers to leverage cutting-edge technology, driving efficiency, precision, and strategic alignment in their project portfolio management."Key AI Features in the New Definitive Pro:AI Assisted Decision Models: This feature enables portfolio managers to rigorously define decision criteria. By "Asking AI," managers can swiftly generate sound and justifiable criteria for robust decision-making models. This integration ensures every decision is underpinned by data-driven insights, effectively and efficiently aligning projects with strategic goals.AI Personas for AHP Pairwise Comparisons: Stakeholder engagement is revolutionized with AI-driven personas such as CTO, CFO, CIO, and CSO. Users can also create custom AI participants. These personas provide expert insights during the Analytic Hierarchy Process (AHP), which is the world's leading technique for establishing the relative importance of decision criteria, enhancing the depth and diversity of perspectives.AI Assisted Business Cases: Creating comprehensive business cases is streamlined with AI assistance. Users can "Ask AI" for help in completing narrative fields. AI-generated suggestions can be incorporated, edited, or appended to existing content, enhancing efficiency, and ensuring high-quality, consistent business case development.AI Business Case Summaries: For busy executives and decision-makers, quickly grasping the essence of a business case is crucial. The AI Business Case Summaries feature provides clear and concise AI-generated summaries, encapsulating key elements and strategic implications. This capability facilitates swift, informed decisions without the need to delve into every detail, thereby enhancing agility and confidence in decision-making.AI Personas for Alternative Evaluation and Scoring: This feature enriches the strategic decision-making process by incorporating AI-based personas into the evaluation and scoring of project alternatives. Users can leverage diverse expert judgments, ensuring a consistent and comprehensive analysis that enhances the quality and reliability of project evaluations.AI-Generated Deliverables: Efficiency in project management is further boosted by automating the creation of critical documents such as project charters, project overview presentations, and statements of work. This capability ensures consistency and precision, reducing the time and effort required from team members, enabling them to focus on strategic decisions and improving overall project delivery.Contact InformationJohn Sammarco President jsammarco@definitiveinc.com (703) 626-0221 Matt Cunningham Business Operations Manager mcunningham@definitiveinc.com (518) 330-5194 Related Videohttps://vimeo.com/928885615 SOURCE: Definitive Business Solutions, Inc.View the original press release on newswire.com.
Definitive Business Solutions Releases AI-Enhanced Version of Definitive Pro for Project Portfolio Management (PPM)
Definitive Pro Elevates Project Portfolio Management (PPM) with Generative AIRESTON, VA / ACCESSWIRE / May 20, 2024 / Definitive Business Solutions, Inc. (Definitive), a leader in innovative project portfolio management solutions, proudly announces the release of the AI-enhanced version of Definitive Pro. This latest iteration of Definitive Pro integrates comprehensive AI features designed to revolutionize how organizations manage their project portfolios, optimizing decision-making and aligning projects seamlessly with strategic objectives.Definitive Logo Definitive Business Solutions, Inc. Logo"In today's dynamic business environment, the ability to make informed, strategic decisions is paramount," said John Sammarco, President of Definitive. "The new AI capabilities in Definitive Pro empower portfolio managers to leverage cutting-edge technology, driving efficiency, precision, and strategic alignment in their project portfolio management."Key AI Features in the New Definitive Pro:AI Assisted Decision Models: This feature enables portfolio managers to rigorously define decision criteria. By "Asking AI," managers can swiftly generate sound and justifiable criteria for robust decision-making models. This integration ensures every decision is underpinned by data-driven insights, effectively and efficiently aligning projects with strategic goals.AI Personas for AHP Pairwise Comparisons: Stakeholder engagement is revolutionized with AI-driven personas such as CTO, CFO, CIO, and CSO. Users can also create custom AI participants. These personas provide expert insights during the Analytic Hierarchy Process (AHP), which is the world's leading technique for establishing the relative importance of decision criteria, enhancing the depth and diversity of perspectives.AI Assisted Business Cases: Creating comprehensive business cases is streamlined with AI assistance. Users can "Ask AI" for help in completing narrative fields. AI-generated suggestions can be incorporated, edited, or appended to existing content, enhancing efficiency, and ensuring high-quality, consistent business case development.AI Business Case Summaries: For busy executives and decision-makers, quickly grasping the essence of a business case is crucial. The AI Business Case Summaries feature provides clear and concise AI-generated summaries, encapsulating key elements and strategic implications. This capability facilitates swift, informed decisions without the need to delve into every detail, thereby enhancing agility and confidence in decision-making.AI Personas for Alternative Evaluation and Scoring: This feature enriches the strategic decision-making process by incorporating AI-based personas into the evaluation and scoring of project alternatives. Users can leverage diverse expert judgments, ensuring a consistent and comprehensive analysis that enhances the quality and reliability of project evaluations.AI-Generated Deliverables: Efficiency in project management is further boosted by automating the creation of critical documents such as project charters, project overview presentations, and statements of work. This capability ensures consistency and precision, reducing the time and effort required from team members, enabling them to focus on strategic decisions and improving overall project delivery.Contact InformationJohn Sammarco President jsammarco@definitiveinc.com (703) 626-0221 Matt Cunningham Business Operations Manager mcunningham@definitiveinc.com (518) 330-5194 Related Videohttps://vimeo.com/928885615 SOURCE: Definitive Business Solutions, Inc.View the original press release on newswire.com.
05/14 16:05 EST - globenewswire.com
Definitive Healthcare to Present at the 52nd Annual J.P. Morgan Global Technology, Media and Communications Conference
FRAMINGHAM, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Founder, Interim CEO, and Executive Chairman, Jason Krantz, will present at the J.P. Morgan Global Technology, Media and Communications Conference.
Definitive Healthcare to Present at the 52nd Annual J.P. Morgan Global Technology, Media and Communications Conference
FRAMINGHAM, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Founder, Interim CEO, and Executive Chairman, Jason Krantz, will present at the J.P. Morgan Global Technology, Media and Communications Conference.
05/13 12:46 EST - zacks.com
DH or PRVA: Which Is the Better Value Stock Right Now?
Investors interested in Medical Info Systems stocks are likely familiar with Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two stocks offers value investors a better bang for their buck right now?
DH or PRVA: Which Is the Better Value Stock Right Now?
Investors interested in Medical Info Systems stocks are likely familiar with Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two stocks offers value investors a better bang for their buck right now?
05/13 10:55 EST - zacks.com
Bears are Losing Control Over Definitive Healthcare (DH), Here's Why It's a 'Buy' Now
Definitive Healthcare (DH) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Bears are Losing Control Over Definitive Healthcare (DH), Here's Why It's a 'Buy' Now
Definitive Healthcare (DH) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
05/11 12:04 EST - seekingalpha.com
Definitive Healthcare Corp. (DH) Q1 2024 Earnings Call Transcript
Definitive Healthcare Corp. (NASDAQ:DH ) Q1 2024 Earnings Conference Call May 7, 2024 5:00 PM ET Company Participants Matthew Ruderman - Investor Relations Jason Krantz - Founder, Executive Chairman and Interim Chief Executive Officer Rick Booth - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Jared Haase - William Blair Matt Shea - Needham & Company Anne Samuel - JPMorgan David Grossman - Stifel Stephanie Davis - Barclays Operator Welcome to Definitive Healthcare's Q1 2024 Earnings Call. Our host for today's call is Jason Krantz.
Definitive Healthcare Corp. (DH) Q1 2024 Earnings Call Transcript
Definitive Healthcare Corp. (NASDAQ:DH ) Q1 2024 Earnings Conference Call May 7, 2024 5:00 PM ET Company Participants Matthew Ruderman - Investor Relations Jason Krantz - Founder, Executive Chairman and Interim Chief Executive Officer Rick Booth - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Jared Haase - William Blair Matt Shea - Needham & Company Anne Samuel - JPMorgan David Grossman - Stifel Stephanie Davis - Barclays Operator Welcome to Definitive Healthcare's Q1 2024 Earnings Call. Our host for today's call is Jason Krantz.